Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid during ...
First in the region to offer comprehensive procedures including Colonic and Antroduodenal Manometry Doha, Qatar: Sidra Medicine, a member of Qatar Foundation, has expanded its diagnostic capabilities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback